Survival after BMT in chronic phase (n = 86) according to duration of pretransplant IFN (±chemotherapy) treatment of more or less than 1 year. Five-year survival is 60% (95% CI: 47 to 73) and 57% (CI: 39 to 74), respectively. This difference is not significant.